Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1416-1426

  Kim, Jin Yeong ^a,b   Song, Haengseok ^a,c   Kim, Hyunjoo ^a   Kang, Hee Jung ^a   Jun, Jin Hyun ^a,d   Hong, Sung Ran ^a   Koong, Mi Kyoung ^a   Kim, In Sun ^b  

^a Kwangdong University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

^d Eulji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; RHO FACTOR;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA REPLICATION; DOWN REGULATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL;

EID: 65249125943     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1612     Document Type: Article

References (33)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
2. Wood JR, Dumesic DA, Abbott DH, Strauss III JF 2007 Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 92:705-713
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
4. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
6. Pache TD, Hop WC, de Jong FH, Leerentveld RA, van Geldrop H, Van de Kamp TM, Gooren LJ,Fauser BC 1992 17 β-Oestradiol, and rostenedione and inhibin levels in fluid from in dividual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol (Oxf) 36:565-571
7. Giudice LC 2006 Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 20:235-244
8. Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le SN, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC 2006 Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 147:1097-1121
9. Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. JClin Endocrinol Metab 84:1897-1899
10. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S 1988 Recurrent early miscarriage and polycystic ovaries. BMJ 297:1027-1028
11. Balen A 2001 Polycystic ovary syndrome and cancer. Hum Reprod Update 7:522-525
12. Hardiman P, Pillay OC, Atiomo W 2003 Polycystic ovary syndrome and endometrial carcinoma. Lancet 361:1810-1812
13. Niwa K, Imai A, Hashimoto M, Yokoyama Y, Mori H, Matsuda Y, Tamaya T 2000 A case-control study of uterine endometrial cancer of pre- and postmenopausal women. Oncol Rep 7:89-93
14. Okon MA, Laird SM, Tuckerman EM, Li TC 1998 Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 69:682-690
15. Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O 1999 Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14:354-358
16. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA 2002 Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66:297-304
17. Maliqueo M, Clementi M, Gabler F, Johnson MC, Palomino A, Sir-Petermann T, Vega M 2003 Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 80(Suppl 2):812-819
18. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss III JF 2003 The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278:26380-26390
19. Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, van den Hurk C, Westland J, Mosselman S, Fauser BC 2004 Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 18:3050-3063
20. Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J, Sha J 2004 The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol 33:59-72
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome- wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
22. 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
23. Koo TB, Song H, Moon I, Han K, Chen C, Murphy K, Lim H2005 Differential expression of the PEA3 subfamily of ETS transcription factors in the mouse ovary and peri-implantation uterus. Reproduction 129:651-657
24. Ehrig T, Abdulkadir SA, Dintzis SM, Milbrandt J, Watson MA 2001 Quantitative amplification of genomic DNA from histological tissue sections after staining with nuclear dyes and laser capture microdissection. J Mol Diagn 3:22-25
25. Saccani JG, Johnston SR, Salter J, Detre S, Dowsett M 1994 Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. J Clin Pathol 47:900 -905
26. Zhong S, Li C, Wong WH 2003 Chiplnfo: software for extracting gene annotation and gene ontology information for microarray analysis. Nucleic Acids Res 31:3483-3486
27. Balen AH, Schachter ME, Montgomery D, Reid RW, Jacobs HS 1993 Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol (Oxf) 38:325-329
28. Navaratnarajah R, Pillay OC, Hardiman P 2008 Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 26:62-71
29. Avellaira C, Villavicencio A, Bacallao K, Gabler F, Wells P, Romero C, Vega M 2006 Expression of molecules associated with tissue homeostasis in secretoryendometria fromuntreated women with polycysticovarysyndrome. Hum Reprod 21:3116-3121
30. Gibson M 1995 Reproductive health and polycystic ovary syndrome. Am J Med 98:67S-75S
31. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA 1992 Integrin adhesion molecules in the human endometrium. Correation with the normal and abnormal menstrual cycle. J Clin Invest 90:188-195
32. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL 1990 The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 70:421-430
33. Shemesh M 2001 Actions of gonadotrophins on the uterus. Reproduction 121:835-842